questionsmedicales.fr
Systèmes sanguin et immunitaire
Système immunitaire
Leucocytes
Granulocytes
Granulocytes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Granulocytes
Granulocytopénie
Numération formule sanguine
Granulocytes
Symptômes
5
Granulocytopénie
Infection
Réaction allergique
Granulocytes
Inflammation
Granulocytes
Infection bactérienne
Granulocytes
Prévention
5
Prévention des infections
Granulocytes
Complications
Granulocytes
Traitements
5
Granulocytopénie
Transfusion
Corticostéroïdes
Inflammation
Greffe de moelle osseuse
Granulocytes
Complications
5
Granulocytopénie
Infection
Leucémie myéloïde
Granulocytes
Cicatrisation
Granulocytes
Immunosuppresseurs
Granulocytes
Effets secondaires
Granulocytes
Facteurs de risque
5
Immunodépression
Infection
Maladies auto-immunes
Granulocytes
Produits chimiques
Granulocytes
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Granulocytes : Questions médicales les plus fréquentes",
"headline": "Granulocytes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Granulocytes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-22",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Granulocytes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Leucocytes",
"url": "https://questionsmedicales.fr/mesh/D007962",
"about": {
"@type": "MedicalCondition",
"name": "Leucocytes",
"code": {
"@type": "MedicalCode",
"code": "D007962",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A15.382.490"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Granulocytes basophiles",
"alternateName": "Basophils",
"url": "https://questionsmedicales.fr/mesh/D001491",
"about": {
"@type": "MedicalCondition",
"name": "Granulocytes basophiles",
"code": {
"@type": "MedicalCode",
"code": "D001491",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A15.382.490.315.120"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Granulocytes éosinophiles",
"alternateName": "Eosinophils",
"url": "https://questionsmedicales.fr/mesh/D004804",
"about": {
"@type": "MedicalCondition",
"name": "Granulocytes éosinophiles",
"code": {
"@type": "MedicalCode",
"code": "D004804",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A15.382.490.315.251"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Granulocytes",
"alternateName": "Granulocytes",
"code": {
"@type": "MedicalCode",
"code": "D006098",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Cathy Conry-Cantilena",
"url": "https://questionsmedicales.fr/author/Cathy%20Conry-Cantilena",
"affiliation": {
"@type": "Organization",
"name": "Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD."
}
},
{
"@type": "Person",
"name": "Michael Gruber",
"url": "https://questionsmedicales.fr/author/Michael%20Gruber",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology, University Hospital Regensburg, Raubling, Germany."
}
},
{
"@type": "Person",
"name": "Hans-Uwe Simon",
"url": "https://questionsmedicales.fr/author/Hans-Uwe%20Simon",
"affiliation": {
"@type": "Organization",
"name": "Institute of Pharmacology, University of Bern, Bern, Switzerland; email: thomas.kaufmann@pki.unibe.ch, hans-uwe.simon@pki.unibe.ch."
}
},
{
"@type": "Person",
"name": "Yu Hao",
"url": "https://questionsmedicales.fr/author/Yu%20Hao",
"affiliation": {
"@type": "Organization",
"name": "Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing 100038, China."
}
},
{
"@type": "Person",
"name": "Can Zhang",
"url": "https://questionsmedicales.fr/author/Can%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing 100038, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Communication Overload in Hospitals: Exploring Organizational Safety Communication, Worker Job Attitudes, and Communication Efficacy.",
"datePublished": "2022-09-29",
"url": "https://questionsmedicales.fr/article/36172847",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/10410236.2022.2129313"
}
},
{
"@type": "ScholarlyArticle",
"name": "Strategic communication as planned behavior for science and risk communication: A theory-based approach to studying communicator choice.",
"datePublished": "2022-09-18",
"url": "https://questionsmedicales.fr/article/36116781",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/risa.14029"
}
},
{
"@type": "ScholarlyArticle",
"name": "Communication Openings: A Novel Approach for Serious Illness Communication in Homecare.",
"datePublished": "2023-11-01",
"url": "https://questionsmedicales.fr/article/37906048",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3928/00989134-20231011-02"
}
},
{
"@type": "ScholarlyArticle",
"name": "Everyday Barriers in Communicative Participation According to People With Communication Problems.",
"datePublished": "2023-02-14",
"url": "https://questionsmedicales.fr/article/36787154",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2022_JSLHR-22-00405"
}
},
{
"@type": "ScholarlyArticle",
"name": "Beyond dyadic communication: Network of communication in inflammatory arthritis teams.",
"datePublished": "2022-05-29",
"url": "https://questionsmedicales.fr/article/35635126",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/17423953221102629"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Systèmes sanguin et immunitaire",
"item": "https://questionsmedicales.fr/mesh/D006424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007107"
},
{
"@type": "ListItem",
"position": 4,
"name": "Leucocytes",
"item": "https://questionsmedicales.fr/mesh/D007962"
},
{
"@type": "ListItem",
"position": 5,
"name": "Granulocytes",
"item": "https://questionsmedicales.fr/mesh/D006098"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Granulocytes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Granulocytes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Granulocytes",
"description": "Comment diagnostiquer une granulocytopénie ?\nQuels tests pour évaluer les granulocytes ?\nQuels signes indiquent une infection liée aux granulocytes ?\nComment évaluer la fonction des granulocytes ?\nQuel rôle joue la biopsie dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=Communication#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Granulocytes",
"description": "Quels symptômes d'une carence en granulocytes ?\nComment se manifeste une réaction allergique ?\nQuels symptômes d'une inflammation ?\nQuels signes d'une infection bactérienne ?\nQuels symptômes d'une leucémie ?",
"url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=Communication#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Granulocytes",
"description": "Comment prévenir les infections chez les patients à faible granulocytes ?\nQuels vaccins sont recommandés ?\nComment éviter les complications liées aux granulocytes ?\nQuel rôle de l'alimentation dans la prévention ?\nComment gérer le stress pour la santé des granulocytes ?",
"url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=Communication#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Granulocytes",
"description": "Comment traiter une granulocytopénie ?\nQuels médicaments stimulent les granulocytes ?\nComment traiter une infection liée aux granulocytes ?\nQuel rôle des corticostéroïdes dans le traitement ?\nQuand envisager une greffe de moelle osseuse ?",
"url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=Communication#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Granulocytes",
"description": "Quelles complications d'une granulocytopénie sévère ?\nQuels risques d'une leucémie myéloïde ?\nComment les granulocytes affectent-ils la cicatrisation ?\nQuelles sont les complications des traitements immunosuppresseurs ?\nQuels effets secondaires des médicaments sur les granulocytes ?",
"url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=Communication#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Granulocytes",
"description": "Quels facteurs augmentent le risque d'infections ?\nQuel rôle des maladies auto-immunes ?\nComment le tabagisme affecte-t-il les granulocytes ?\nQuels risques liés à l'exposition aux produits chimiques ?\nQuel impact de la génétique sur les granulocytes ?",
"url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=Communication#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une granulocytopénie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un hémogramme révèle une diminution des granulocytes dans le sang."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer les granulocytes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins comme la numération formule sanguine sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection liée aux granulocytes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue et inflammation peuvent signaler une infection."
}
},
{
"@type": "Question",
"name": "Comment évaluer la fonction des granulocytes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de phagocytose et de dégranulation peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la biopsie dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie médullaire peut aider à évaluer la production de granulocytes."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une carence en granulocytes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections fréquentes, fièvre et fatigue sont des symptômes courants."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une réaction allergique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éruptions cutanées, démangeaisons et œdème peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une inflammation ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur, gonflement et douleur sont des signes d'inflammation."
}
},
{
"@type": "Question",
"name": "Quels signes d'une infection bactérienne ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, frissons et douleur localisée peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une leucémie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, ecchymoses et infections fréquentes peuvent être présents."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections chez les patients à faible granulocytes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène et éviter les foules sont essentiels."
}
},
{
"@type": "Question",
"name": "Quels vaccins sont recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins contre la grippe et le pneumocoque sont souvent conseillés."
}
},
{
"@type": "Question",
"name": "Comment éviter les complications liées aux granulocytes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller les signes d'infection et consulter rapidement un médecin."
}
},
{
"@type": "Question",
"name": "Quel rôle de l'alimentation dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée renforce le système immunitaire."
}
},
{
"@type": "Question",
"name": "Comment gérer le stress pour la santé des granulocytes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de relaxation peuvent aider à réduire le stress."
}
},
{
"@type": "Question",
"name": "Comment traiter une granulocytopénie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des transfusions de granulocytes ou des médicaments stimulants peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels médicaments stimulent les granulocytes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le filgrastim et le pegfilgrastim sont des agents couramment utilisés."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection liée aux granulocytes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antibiotiques sont prescrits pour traiter les infections bactériennes."
}
},
{
"@type": "Question",
"name": "Quel rôle des corticostéroïdes dans le traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent réduire l'inflammation et moduler la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Quand envisager une greffe de moelle osseuse ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "En cas de maladies graves affectant la production de granulocytes."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une granulocytopénie sévère ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections graves, septicémie et complications hémorragiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels risques d'une leucémie myéloïde ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Risque accru d'infections et de saignements en raison de la production anormale."
}
},
{
"@type": "Question",
"name": "Comment les granulocytes affectent-ils la cicatrisation ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une diminution des granulocytes peut retarder la cicatrisation des plaies."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications des traitements immunosuppresseurs ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections opportunistes et cancers peuvent survenir avec ces traitements."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires des médicaments sur les granulocytes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent entraîner une diminution des granulocytes."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infections ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une immunodépression, le diabète et l'âge avancé augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quel rôle des maladies auto-immunes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner une destruction accrue des granulocytes."
}
},
{
"@type": "Question",
"name": "Comment le tabagisme affecte-t-il les granulocytes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme peut altérer la fonction des granulocytes et augmenter l'inflammation."
}
},
{
"@type": "Question",
"name": "Quels risques liés à l'exposition aux produits chimiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains produits chimiques peuvent endommager la moelle osseuse et réduire les granulocytes."
}
},
{
"@type": "Question",
"name": "Quel impact de la génétique sur les granulocytes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des prédispositions génétiques peuvent influencer la production et la fonction des granulocytes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 17/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Publications dans "Granulocytes" :
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology, University Hospital Regensburg, Raubling, Germany.
Publications dans "Granulocytes" :
2 publications dans cette catégorie
Affiliations :
Institute of Pharmacology, University of Bern, Bern, Switzerland; email: thomas.kaufmann@pki.unibe.ch, hans-uwe.simon@pki.unibe.ch.
Department of Clinical Immunology and Allergology, Sechenov University, Moscow, Russia.
Laboratory of Molecular Immunology, Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Brandenburg Medical School, Neuruppin, Germany.
Publications dans "Granulocytes" :
2 publications dans cette catégorie
Affiliations :
Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing 100038, China.
Publications dans "Granulocytes" :
2 publications dans cette catégorie
Affiliations :
Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing 100038, China.
Publications dans "Granulocytes" :
2 publications dans cette catégorie
Affiliations :
Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing 100038, China.
Publications dans "Granulocytes" :
2 publications dans cette catégorie
Affiliations :
Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing 100038, China.
Publications dans "Granulocytes" :
2 publications dans cette catégorie
Affiliations :
Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing 100038, China.
Publications dans "Granulocytes" :
2 publications dans cette catégorie
Affiliations :
Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing 100038, China. Electronic address: zhangju@mail.ccmu.edu.cn.
Publications dans "Granulocytes" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Immunology, Jagiellonian University Medical College, 30-663 Krakow, Poland.
Publications dans "Granulocytes" :
1 publication dans cette catégorie
Affiliations :
Laboratory Medicine, Faculty of Pharmacy, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Publications dans "Granulocytes" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Immunology, Jagiellonian University Medical College, 30-663 Krakow, Poland.
Publications dans "Granulocytes" :
1 publication dans cette catégorie
Affiliations :
Cayuga Medical Center, 101 Dates Drive, Ithaca, NY 14850, USA; Weill Cornell Medicine. Electronic address: dmac92077@gmail.com.
Publications dans "Granulocytes" :
1 publication dans cette catégorie
Affiliations :
Cayuga Medical Center, 101 Dates Drive, Ithaca, NY 14850, USA.
Publications dans "Granulocytes" :
1 publication dans cette catégorie
Affiliations :
Department of Animal Morphology, Physiology and Genetics, Faculty of AgriSciences, Mendel University in Brno, Zemedelska 1, 613 00 Brno, Czech Republic.
Publications dans "Granulocytes" :
1 publication dans cette catégorie
Affiliations :
Department of Animal Morphology, Physiology and Genetics, Faculty of AgriSciences, Mendel University in Brno, Zemedelska 1, 613 00 Brno, Czech Republic.
Publications dans "Granulocytes" :
1 publication dans cette catégorie
Affiliations :
Department of Animal Morphology, Physiology and Genetics, Faculty of AgriSciences, Mendel University in Brno, Zemedelska 1, 613 00 Brno, Czech Republic.
Publications dans "Granulocytes" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Studies, University of Pennsylvania, New Bolton Center, 382 West Street Road, Kennett Square, PA 19348, USA.
Publications dans "Granulocytes" :
1 publication dans cette catégorie
Affiliations :
Department of Comparative Pathobiology, Tufts University, Cummings School of Veterinary Medicine, 200 Westboro Road, North Grafton, MA 01536, USA.
Publications dans "Granulocytes" :
1 publication dans cette catégorie
Affiliations :
Department of Clinical Studies, University of Pennsylvania, New Bolton Center, 382 West Street Road, Kennett Square, PA 19348, USA. Electronic address: rnolenw@upenn.edu.
Publications dans "Granulocytes" :
Hospitals represent complex organizations where a range of hospital workers, from physicians to administrators, encounter a deluge of information they must quickly process and act upon. New technologi...
This essay argues that we should treat science and risk communicators' choices about tactics, objectives, and goals as behaviors to advance both research and practice. Doing so allows for a discussion...
Serious illness communication in homecare about hospice and/or palliative care transitions is lacking due to clinical culture. The purpose of the current study was to understand communication openings...
The purpose of this study was to gain a comprehensive understanding of participation situations that are challenging for people with communication problems, to provide input for the further developmen...
A purposive sampling strategy was used to include a diverse group of people with communication problems. Diaries were used as a sensitizing exercise for inductive in-depth interviews. In these intervi...
Eighteen interviews yielded 44 different concepts. They were clustered in six themes, which capture the person, location, topic, mode, moment, and pace of communication. In total, 103 new items measur...
This study resulted in an overview of self-reported barriers in daily communicative participation experienced by people with communication problems. These communicative participation situations can be...
To explore how communication is perceived and care is negotiated amongst IA healthcare teams by drawing on the perspectives of each team member....
This analysis drew on data from an ongoing three-year study exploring team-based IA care. We interviewed 11 participants including two men with IA and their family care providers and healthcare provid...
Analysis revealed three themes regarding communication and care: (1) seeking/sharing information, (2) striving to coordinate unified care, and (3) providing patients a voice....
This study emphasizes the importance of understanding team dynamics beyond the dyad of patient and care provider. Negotiating power and decision-making in IA care is a dynamic process involving shifti...
To analyze the effect of communication training developed for adolescents on the youth's communication skills....
Forty-one young people participated in the study and were divided into two groups. Group I received intervention - communication training for five weeks; Group II - were guided on the importance of vo...
The analysis of questionnaires showed improvement in GI in two of the four skills assessed and no difference for GII. The video evaluations showed a significant difference between the groups in terms ...
This study points out that the communication training method applied to young people might improve communicative skills, providing some insights into their communication strengths and potential areas ...
Humans often communicate using body movements like winks, waves, and nods. However, it is unclear how we identify when someone's physical actions are communicative. Given people's propensity to interp...
The consequences of ineffective communication between patients and clinicians in the ED range from frustration to significant adverse events. Unfortunately, scenarios where we are unable to understand...
Many people with amyotrophic lateral sclerosis (PALS) experience speech changes, which may interfere with participation in communication situations. This study was designed to investigate the effects ...
Participants with amyotrophic lateral sclerosis completed an online questionnaire in which they identified their current communication methods, rated their speech function, and rated their communicati...
Communication aids appeared to support communicative participation for many participants with dysarthria. Across all levels of speech function, PALS who use aided communication reported better partici...
Aided communication can help PALS continue to participate in various communication situations as their speech function deteriorates. Variability in self-rated communicative participation, even for PAL...
https://doi.org/10.23641/asha.22782986....
Research has found that people with communication disabilities are three times more likely to encounter medical mishaps. Almost a third of patients with speech-language therapy (SLT) diagnoses have ot...
This study aims to describe the communication challenges and strategies employed by a group of final year Nursing, Medicine, Dietetics and Human Nutrition, Physiotherapy and Occupational Therapy stude...
A qualitative, phenomenological study design was used. Questionnaires were electronically distributed, and results were analysed thematically....
The most significant challenges whilst managing adults with communication disorders were patients' receptive and expressive language difficulties. Further challenges included lack of knowledge surroun...
This study revealed that there is a need to develop healthcare students' skills in managing adults with communication disorders. This is because of the challenges faced and inefficiency of the strateg...